Erbez Georgia
SEC-identified person · CIK 1557930 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Codexis, INC. CDXS | See Remarks | filed 2024–2026 |
| Coherus Oncology, Inc. CHRS | Director | filed 2024–2025 |
| Sierra Oncology, Inc. SRRA | Director | filed 2021–2022 |
| Harpoon Therapeutics, Inc. HARP | Chief Financial Officer | filed 2019–2022 |
| Artelo Biosciences, INC. ARTL | Director | filed 2019–2019 |
| Zosano Pharma Corp ZSAN | Interim CFO | filed 2016–2017 |
| Asterias Biotherapeutics, Inc. ASTY | Exec VP & CFO | filed 2015–2015 |
| Torreypines Therapeutics, Inc. TPTX | Chief Financial Officer | filed 2012–2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.